Efficacy, Safety and the Lymphocyte Subset Changes of Low-Dose IL-2 in Patients with Autoimmune Rheumatic Diseases: A Systematic Review and Meta-Analysis.
Qinyi SuXinmiao WangYongzhi LiJiexiang ZhangCairui BaiXuechun WangLiu YangJingting ZhangSheng-Xiao ZhangPublished in: Rheumatology and therapy (2023)
Retrospectively registered (CRD42022318916, 21/04/2022).